Cytotoxicity of atorvastatin and simvastatin on primary rainbow trout (Oncorhynchus mykiss) hepatocytes

被引:35
作者
Ellesat, Kathrin Sabine [1 ]
Tollefsen, Knut-Erik [2 ]
Asberg, Anders [3 ]
Thomas, Kevin V. [2 ]
Hylland, Ketil [1 ,2 ]
机构
[1] Univ Oslo, Dept Biol, N-0316 Oslo, Norway
[2] Norwegian Inst Water Res NIVA, N-0349 Oslo, Norway
[3] Univ Oslo, Sch Pharm, N-0316 Oslo, Norway
关键词
Atorvastatin; Simvastatin; Cytotoxicity; Hepatocytes; Rainbow trout; COA REDUCTASE INHIBITOR; COENZYME-A REDUCTASE; ALKYLATED NON-PHENOLICS; LIPID-LOWERING DRUGS; SKELETAL-MUSCLE; HAZARD ASSESSMENT; SURFACE WATERS; LACTONE FORMS; IN-VITRO; PHARMACEUTICALS;
D O I
10.1016/j.tiv.2010.06.006
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 [卫生毒理学];
摘要
Statins are cholesterol-lowering pharmaceuticals and commonly prescribed drugs in European countries. Their discharge into the aquatic environment has increased in the last few years and they are present at detectable levels in most sewage effluents. The aim of the present study was to quantify the cytotoxic effects of acid and lactone forms of two statins. atorvastatin and simvastatin, as well as selected metabolites (ortho- and para-hydroxy atorvastatin acid, ortho-hydroxy atorvastatin lactone, simvastatin hydroxyl carboxylic acid, and 3 '' hydroxy simvastatin lactone) to hepatocytes from rainbow trout (Oncorhynchus mykiss). Hepatocytes were exposed for 24, 48, and 72 h to different concentrations of each test substance (0.4-400 mu M). Cytotoxicity was measured as metabolic inhibition and loss of membrane integrity with the fluorescent probes alamar blue (AB) and 5-carboxyfluorescein diacetate, acetoxymethyl ester (CFDA-AM), respectively. Atorvastatin, simvastatin, and ortho-hydroxy atorvastatin lactone had dose-dependent cytotoxic effects on hepatocytes. Simvastatin was more toxic than atorvastatin and the lactone form more toxic than the acid form. Exposure time affected atorvastatin and ortho-hydroxy atorvastatin lactone but not simvastatin toxicity. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1610 / 1618
页数:9
相关论文
共 59 条
[1]
[Anonymous], 2004, INT C SER, DOI DOI 10.1016/J.ICS.2003.12.099
[2]
[Anonymous], 1999, Biostatistical Analysis
[3]
Arukwe A, 1997, J EXP ZOOL, V277, P313, DOI 10.1002/(SICI)1097-010X(19970301)277:4<313::AID-JEZ5>3.0.CO
[4]
2-S
[5]
Human pharmaceuticals in surface waters implementation of a prioritization methodology and application to the French situation [J].
Besse, Jean-Philippe ;
Garric, Jeanne .
TOXICOLOGY LETTERS, 2008, 176 (02) :104-123
[6]
Black AE, 1999, DRUG METAB DISPOS, V27, P916
[7]
Herbicidal effects of statin pharmaceuticals in Lemna gibba [J].
Brain, Richard A. ;
Reitsma, Tamara S. ;
Lissemore, Linda I. ;
Bestari, Ketut ;
Sibley, Paul K. ;
Solomon, Keith R. .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2006, 40 (16) :5116-5123
[8]
Evidence that hormesis represents an "overcompensation" response to a disruption in homeostasis [J].
Calabrese, EJ .
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 1999, 42 (02) :135-137
[9]
Cytotoxicity of pharmaceuticals found in aquatic systems: Comparison of PLHC-1 and RTG-2 fish cell lines [J].
Caminada, Daniel ;
Escher, Claudia ;
Fent, Karl .
AQUATIC TOXICOLOGY, 2006, 79 (02) :114-123
[10]
Differential interaction of 3-hydroxy-3-methylglutaryl-COA reductase inhibitors with ABCB1, ABCC2, and OATP1B1 [J].
Chen, CP ;
Mireles, RJ ;
Campbell, SD ;
Lin, J ;
Mills, JB ;
Xu, JHJ ;
Smolarek, TA .
DRUG METABOLISM AND DISPOSITION, 2005, 33 (04) :537-546